JMVQX | JVMSX | JMVQX / JVMSX | |
Total Expense Ratio | 0.85 | 1.24 | 69% |
Annual Report Gross Expense Ratio | 0.94 | 1.25 | 75% |
Fund Existence | 9 years | 14 years | - |
Gain YTD | 2.750 | 9.399 | 29% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12B | 23.9B | 50% |
Annual Yield % from dividends | 0.81 | 0.40 | 202% |
Returns for 1 year | -9.80 | -5.30 | 185% |
Returns for 3 years | 5.48 | 24.28 | 23% |
Returns for 5 years | 10.20 | 45.42 | 22% |
Returns for 10 years | N/A | 47.59 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
OMAH | 19.03 | 0.23 | +1.22% |
Vistashares Target 15 Berkshire Select Income ETF | |||
RWM | 16.70 | 0.12 | +0.72% |
ProShares Short Russell2000 | |||
XIDE | 30.28 | 0.03 | +0.10% |
FT Vest U.S. Eq Buf & PrmIncETF-Dec | |||
HQL | 16.50 | -0.08 | -0.48% |
abrdn Life Sciences Investors | |||
GUNR | 43.55 | -0.35 | -0.80% |
FlexShares Mstar Glbl Upstrm Nat Res ETF |